Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Efficacy and safety of selpercatinib in RET fusion-positive cancers other than l...
Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA
Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )
13 Apr 2021
First-line pembrolizumab plus chemotherapy for patients with advanced squamous N...
Dr Andrew Robinson - Cancer Centre of Southeastern Ontario at Kingston General H...
First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year follow-up from KEYNOTE-407 ( Dr Andrew Robinson - Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, Canada )
9 Apr 2021
MERMAID-2: Phase 3 study of durvalumab in patients with resected stage MRD II-I...
Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA
MERMAID-2: Phase 3 study of durvalumab in patients with resected stage MRD  II-III NSCLC ( Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA )
9 Apr 2021
Cemiplimab plus ipilimumab for advanced NSCLC
Prof Byoung Yong Shim - The Catholic University of Korea, Suwon, South Korea
Cemiplimab plus ipilimumab for advanced NSCLC ( Prof Byoung Yong Shim - The Catholic University of Korea, Suwon, South Korea )
7 Apr 2021
Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small ...
Dr Erminia Massarelli - City of Hope, Duarte, USA
Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small cell lung cancer ( Dr Erminia Massarelli - City of Hope, Duarte, USA )
1 Apr 2021
Incorporating KRAS as a novel biomarker: Challenges and opportunities
Prof Ales Ryska - Charles University, Prague, Czech Republic
Incorporating KRAS as a novel biomarker: Challenges and opportunities ( Prof Ales Ryska - Charles University, Prague, Czech Republic )
29 Mar 2021
Real world data and diagnostics in patients with NSCLC with EGFR exon 20 inserti...
Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio Passa...
Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertions ( Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio Passaro )
29 Mar 2021
Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC i...
Prof Andrea Filippi - University of Pavia, Pavia, Italy
Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC ineligible for chemotherapy ( Prof Andrea Filippi - University of Pavia, Pavia, Italy )
26 Mar 2021
OncoAlert and ecancer weekly roundup for March 01 - 06, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for March 01 - 06, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Mar 2021
Managing the treatment of NSCLC patients during the COVID-19 pandemic (ES)
Dr Giuseppe Giaccone, Dr Marina Garassino
Managing the treatment of NSCLC patients during the COVID-19 pandemic (ES) ( Dr Giuseppe Giaccone, Dr Marina Garassino )
2 Mar 2021
Managing the treatment of NSCLC patients during the COVID-19 pandemic (IT)
Dr Giuseppe Giaccone, Dr Marina Garassino
Managing the treatment of NSCLC patients during the COVID-19 pandemic (IT) ( Dr Giuseppe Giaccone, Dr Marina Garassino )
2 Mar 2021
Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE)
Dr Giuseppe Giaccone, Dr Marina Garassino
Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE) ( Dr Giuseppe Giaccone, Dr Marina Garassino )
2 Mar 2021